CREATING DRUGS AT THE SPEED OF AI
LIVE

Serial Number

99137351

Owner

Absci Corporation

Attorney

Tiffany D. Gehrke

Filing Date

Apr 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CREATING DRUGS AT THE SPEED OF AI Trademark

Serial Number: 99137351

CREATING DRUGS AT THE SPEED OF AI is a trademark filed by Absci Corporation on April 15, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Absci Corporation

18105 SE Mill Plain Blvd.
Vancouver, WA 98683

Entity Type: 03

Trademark Details

Filing Date

April 15, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; biotechnical and pharmacological laboratory services for biomanufacturing, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research, namely, scientific research, development, analysis, producing, testing, in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations, and scientific research consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; development of pharmaceutical preparations, medicines and medicaments; technological consultancy services, namely, technological consultation in the field of biotechnology, namely, production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; development of pharmaceutical preparations in the nature of computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, development of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, development of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragments

Biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services in the nature of custom biomanufacturing of pharmaceutical preparations, namely, custom production of cell lines to produce proteins, namely, hormones, cytokines, antibodies and antibody fragments

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 8, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 8, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 8, 2026 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 9, 2025 XELR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 10, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 15, 2025 MAFR
NEW APPLICATION ENTERED
Apr 15, 2025 NWAP